Kura Oncology, Inc. (KURA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 18.27M | 17.34M | 20.75M | 15.29M | 14.11M | 53.88M | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 29.47% | -67.83% | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 617K | 0 | 3.21M | 0 | 0 | 0 | 0 | 202K | 234K | 214K | 216K | 0 |
| COGS % of Revenue | 3.38% | - | 15.48% | - | - | - | - | - | - | - | - | - |
| Gross Profit | 17.65M | 17.34M | 17.54M | 15.29M | 14.11M | 53.88M | 0 | -202K | -234K | -214K | -216K | 0 |
| Gross Margin % | 96.62% | 100% | 84.52% | 100% | 100% | 100% | - | - | - | - | - | - |
| Gross Profit Growth % | 25.09% | -67.83% | - | 7668.32% | 6129.06% | 25278.97% | 100% | - | - | - | - | - |
| Operating Expenses | 96.46M | 103.6M | 97.53M | 87.95M | 78.81M | 76.34M | 59.88M | 56.2M | 54.22M | 46.55M | 42.26M | 40M |
| OpEx % of Revenue | 528.13% | 597.62% | 470.05% | 575.31% | 558.61% | 141.67% | - | - | - | - | - | - |
| Selling, General & Admin | 31.2M | 39.14M | 32.84M | 25.17M | 22.84M | 24.07M | 18.18M | 16.48M | 17.95M | 14.02M | 12.93M | 11.82M |
| SG&A % of Revenue | 170.82% | 225.77% | 158.26% | 164.63% | 161.86% | 44.67% | - | - | - | - | - | - |
| Research & Development | 65.26M | 64.41M | 67.91M | 62.78M | 55.97M | 52.27M | 41.7M | 39.73M | 36.27M | 32.53M | 29.33M | 28.18M |
| R&D % of Revenue | 357.31% | 371.53% | 327.27% | 410.68% | 396.75% | 97% | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 57K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -78.81M | -86.27M | -80M | -72.67M | -64.7M | -22.45M | -59.88M | -56.4M | -54.45M | -46.76M | -42.47M | -40M |
| Operating Margin % | -431.51% | -497.62% | -385.53% | -475.31% | -458.61% | -41.67% | - | - | - | - | - | - |
| Operating Income Growth % | -21.82% | -284.18% | -33.59% | -28.83% | -18.82% | 51.98% | -40.99% | -41% | -48.91% | -33.01% | -16.07% | -13.22% |
| EBITDA | -78.46M | -85.86M | -79.83M | -72.44M | -71.81M | -22.25M | -59.68M | -56.2M | -54.22M | -46.55M | -42.26M | -39.79M |
| EBITDA Margin % | -429.56% | -495.3% | -384.74% | -473.85% | -509.04% | -41.3% | - | - | - | - | - | - |
| EBITDA Growth % | -9.25% | -285.89% | -33.78% | -28.9% | -32.46% | 52.2% | -41.22% | -41.25% | -49.11% | -33.18% | -16.09% | -13.2% |
| D&A (Non-Cash Add-back) | 355K | 403K | 164K | 224K | -7.12M | 204K | 208K | 202K | 234K | 214K | 216K | 213K |
| EBIT | -78.81M | -80.58M | -74.12M | -65.73M | -57.59M | -16.8M | -53.99M | -50.43M | -49.13M | -42.39M | -38.2M | -36.79M |
| Net Interest Income | 5.49M | 5.34M | 5.88M | 6.54M | 7.5M | 5.26M | 5.48M | 5.57M | 4.93M | 3.98M | 3.87M | 2.83M |
| Interest Income | 5.83M | 5.69M | 5.88M | 6.93M | 7.88M | 5.66M | 5.89M | 5.97M | 5.33M | 4.37M | 4.28M | 3.22M |
| Interest Expense | 336K | 346K | 0 | 391K | 382K | 403K | 412K | 406K | 398K | 394K | 404K | 387K |
| Other Income/Expense | 5.49M | 5.34M | 5.88M | 6.54M | 7.5M | 5.26M | 5.48M | 5.57M | 4.93M | 3.98M | 3.87M | 2.83M |
| Pretax Income | -73.33M | -80.93M | -74.12M | -66.12M | -57.2M | -17.2M | -54.4M | -50.84M | -49.52M | -42.79M | -38.6M | -37.17M |
| Pretax Margin % | -401.45% | -466.82% | -357.19% | -432.51% | -405.46% | -31.92% | - | - | - | - | - | - |
| Income Tax | 8K | 71K | 0 | 0 | 226K | 2.02M | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.01% | -0.09% | 0% | 0% | -0.4% | -11.73% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -73.33M | -81M | -74.12M | -66.12M | -57.43M | -19.22M | -54.4M | -50.84M | -49.52M | -42.79M | -38.6M | -37.17M |
| Net Margin % | -401.49% | -467.23% | -357.19% | -432.51% | -407.07% | -35.66% | - | - | - | - | - | - |
| Net Income Growth % | -27.69% | -321.5% | -36.23% | -30.07% | -15.96% | 55.09% | -40.94% | -36.75% | -45.37% | -29.21% | -8.73% | -6.92% |
| Net Income (Continuing) | -73.33M | -81M | -74.12M | -66.12M | -57.43M | -19.22M | -54.4M | -50.84M | -49.52M | -42.79M | -38.6M | -37.17M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.83 | -0.92 | -0.85 | -0.75 | -0.66 | -0.22 | -0.63 | -0.59 | -0.59 | -0.55 | -0.50 | -0.53 |
| EPS Growth % | -25.76% | -318.18% | -34.92% | -27.12% | -11.86% | 60% | -26% | -11.32% | -18% | -12.24% | 5.66% | -1.92% |
| EPS (Basic) | -0.83 | -0.92 | -0.85 | -0.75 | -0.66 | -0.22 | -0.63 | -0.59 | -0.59 | -0.55 | -0.50 | -0.53 |
| Diluted Shares Outstanding | 88.61M | 88.05M | 87.64M | 87.59M | 87.42M | 87.14M | 86.95M | 86.64M | 83.91M | 77.34M | 77.24M | 69.8M |
| Basic Shares Outstanding | 88.61M | 88.05M | 87.65M | 87.59M | 87.42M | 87.14M | 86.95M | 86.64M | 83.91M | 77.34M | 77.24M | 69.8M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |